GlassScriptPhysician profile
Diana Leblanc
NPI 1861680308
$776.98
in general payments reported to CMS, 2019-2025
8 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $34.50 · 2021: $28.98 · 2022: $139 · 2023: $170 · 2024: $194 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $236.34 | 2020-2025 | Menopur |
| Abbvie INC. | $207.34 | 2022-2025 | |
| Organon LLC | $191.75 | 2023-2025 | Pregnyl, Ganirelix Acetate, Follistim Aq |
| Emd Serono, INC. | $53.91 | 2024-2025 | |
| Astellas Pharma US INC | $36.14 | 2024-2025 | Veozah |
| Myovant Sciences INC. | $22.52 | 2022 | |
| Merck Sharp & Dohme LLC | $16.67 | 2021 | |
| Virtus Pharmaceuticals LLC | $12.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Leblanc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.